DESTINY NEW: Open Payments
NPI 1528578051 · TYLER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,397 in 71 payments from 13 companies in 2025. Trend: 2023 $1,346 · 2024 $1,999 · 2025 $1,397
Food & beverage: $1,316Education: $82
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 10 | $216 |
| UCB, Inc. | 9 | $207 |
| ABBVIE INC. | 15 | $192 |
| Novartis Pharmaceuticals Corporation | 9 | $190 |
| Lilly USA, LLC | 8 | $158 |
| Janssen Biotech, Inc. | 4 | $133 |
| Regeneron Healthcare Solutions, Inc. | 4 | $85 |
| Galderma Laboratories, L.P. | 4 | $74 |
| PFIZER INC. | 2 | $35 |
| E.R. Squibb & Sons, L.L.C. | 2 | $33 |
Products named: DUPIXENT, Bimzelx, TALTZ, TREMFYA, SKYRIZI, RINVOQ, NEMLUVIO, COSENTYX.
Industry payments across TX — which companies pay providers there.
